


FDA Action on Loperamide Misuse; Plus Phase 1 Trials for BAT2506 Biosimilar Begin

Ethics Forum: Patient Safety at Home—What Are Our Legal & Ethical Responsibilities?

FDA Receives Reports of Loperamide Abuse

Rheumatology Drug Updates: Opana ER Painkiller Pulled from U.S. Market; Upadacitinib to Treat RA, and More
U.S. Panel Backs Approval of Abuse-Resistant Opioid Painkiller
